Alternatived Products of [ 278779-30-9 ]
Product Details of [ 278779-30-9 ]
CAS No. : | 278779-30-9 |
MDL No. : | MFCD09971006 |
Formula : |
C28H22Cl3NO4
|
Boiling Point : |
- |
Linear Structure Formula : | - |
InChI Key : | BYTNEISLBIENSA-MDZDMXLPSA-N |
M.W : |
542.84
|
Pubchem ID : | 9893571 |
Synonyms : |
|
Chemical Name : | 3-(2-Chloro-4-((3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl)methoxy)styryl)benzoic acid |
Calculated chemistry of [ 278779-30-9 ] Expand+
Physicochemical Properties
Num. heavy atoms : |
36 |
Num. arom. heavy atoms : |
23 |
Fraction Csp3 : |
0.14 |
Num. rotatable bonds : |
8 |
Num. H-bond acceptors : |
5.0 |
Num. H-bond donors : |
1.0 |
Molar Refractivity : |
144.86 |
TPSA : |
72.56 ?2 |
Pharmacokinetics
GI absorption : |
Low |
BBB permeant : |
No |
P-gp substrate : |
Yes |
CYP1A2 inhibitor : |
No |
CYP2C19 inhibitor : |
No |
CYP2C9 inhibitor : |
No |
CYP2D6 inhibitor : |
No |
CYP3A4 inhibitor : |
No |
Log Kp (skin permeation) : |
-3.69 cm/s |
Lipophilicity
Log Po/w (iLOGP) : |
4.36 |
Log Po/w (XLOGP3) : |
8.34 |
Log Po/w (WLOGP) : |
8.5 |
Log Po/w (MLOGP) : |
5.57 |
Log Po/w (SILICOS-IT) : |
8.49 |
Consensus Log Po/w : |
7.05 |
Druglikeness
Lipinski : |
2.0 |
Ghose : |
None |
Veber : |
0.0 |
Egan : |
1.0 |
Muegge : |
1.0 |
Bioavailability Score : |
0.56 |
Water Solubility
Log S (ESOL) : |
-8.4 |
Solubility : |
0.00000214 mg/ml ; 0.0000000039 mol/l |
Class : |
Poorly soluble |
Log S (Ali) : |
-9.73 |
Solubility : |
0.000000101 mg/ml ; 0.0000000002 mol/l |
Class : |
Poorly soluble |
Log S (SILICOS-IT) : |
-10.84 |
Solubility : |
0.0000000078 mg/ml ; 0.0 mol/l |
Class : |
Insoluble |
Medicinal Chemistry
PAINS : |
0.0 alert |
Brenk : |
1.0 alert |
Leadlikeness : |
3.0 |
Synthetic accessibility : |
4.22 |
Safety of [ 278779-30-9 ]
Signal Word: | Warning |
Class: | N/A |
Precautionary Statements: | P305+P351+P338 |
UN#: | N/A |
Hazard Statements: | H302-H319-H413 |
Packing Group: | N/A |
GHS Pictogram: |
|